Healthcare and Pharmaceuticals industry

Global Prostate Cancer Therapeutics Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Prostate cancer is the most common cancer among the geriatric male population. It is a major health concern, especially in developed countries with a greater proportion of elderly men being affected by it. According to European Association of Urology, 2016, the incidence is highest in Northern and Western Europe (> 200 per 100,000 men with age group > 70 years of age), while rates in Eastern and Southern Europe have showed a continuous increase. Thus, the introduction of innovative drugs for patients with prostate cancer is required to meet the unmet needs with satisfactory results. Currently, metastatic castration-resistant prostate cancer (CRPC) is usually treated with chemotherapy (docetaxel, and cabazitaxel) or secondary hormonal therapeutic agents such as abiraterone or Triptorelin. Immunotherapy with Sipuleucel-T is prescribed in treating asymptomatic or minimally metastatic CRPC without visceral metastasis.
Market Dynamics
The market is gaining significant traction due to continuous investment by research organizations and universities for the development of therapeutic products for the treatment of such tumors. Novel therapies are expected to be predominately approved in castration-resistant patients, and to compete with better-established treatments, such as Zytiga, Xtandi and generic docetaxel, or to act as adjuvants to established therapies. For instance, there is a strong pipeline of products such as Metformin (Mansoura University), Avelumab (Duke University Medical Center), LY2452473 (Dana-Farber Cancer Institute), which are in their phase 2 studies and are projected to enter the market in the near future. However, high cost and side effects associated with drugs can restraint the market growth.
Key features of the study:

This report provides in-depth analysis of the prostate cancer therapeutics market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global prostate cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Johnson & Johnson, Astella, Inc, Sanofi-Aventis, Bayer AG, AstraZeneca Plc, Pfizer Inc., Dendreon Corporation (Sanpower Group Co. Ltd.), Ipsen Group, Tolmar Inc, Endo Pharmaceuticals, AbbVie, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global prostate cancer therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for prostate cancer therapeutics market, research and consulting firms, new entrants and financial analysts
Various strategy matrices used in analyzing the prostate cancer therapeutics market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Global Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Prostate Cancer Therapeutics Market, By Geography:

North America

U.S.

U.S. Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



U.S. Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Canada

Canada Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Canada Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies



Europe

U.K.

U.K. Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



U.K. Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Germany

Germany Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Germany Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Italy

Italy Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Italy Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


France

France Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



France Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Spain

Spain Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Spain Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Russia

Russia Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Russia Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Rest of Europe

Rest of Europe Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Rest of Europe Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies



Asia-Pacific

China

China Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)




India

India Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



India Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Japan

Japan Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Japan Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


ASEAN

ASEAN Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



ASEAN Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Australia

Australia Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Australia Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


South Korea

South Korea Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



South Korea Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Rest of Asia Pacific

Rest of Asia Pacific Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Rest of Asia Pacific Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies



Latin America

Brazil

Brazil Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Brazil Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Mexico

Mexico Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Mexico Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Rest of Latin America

Rest of Latin America Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Rest of Latin America Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies



Middle East

GCC

GCC Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



GCC Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Israel

Israel Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Israel Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Rest of Middle East

Rest of Middle East Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Rest of Middle East Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies



Africa

North Africa

North Africa Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



North Africa Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


Central Africa

Central Africa Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



Central Africa Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies


South Africa

South Africa Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)



South Africa Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies




Company Profiles

Johnson & Johnson

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Astellas Pharma Inc.
AstraZeneca Plc
Sanofi
Bayer AG
Pfizer, Inc.
Dendreon Corporation (Sanpower Group Co. Ltd.)
Ipsen Group
Tolmar Inc.
Endo International plc
AbbVie, Inc.


 “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Drug Type
? Market Snippet, By Distribution Channel
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Impact Analysis
o Regulatory Scenario
o Reimbursement Scenario
o Pipeline Analysis
o PEST Analysis
o PORTER'S Five Forces
4. Global Prostate Cancer Therapeutics Market, By Drug Type, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Hormonal Therapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Abiraterone Acetate (Zytiga)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Degarelix Acetate (Firmagon/Gonax)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Luteinizing Hormone-Releasing Hormone (LHRH) Agonist
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Goserelin Acetate (Zoladex)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Leuprorelin Acetate (Prostap or Lutrate)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Triptorelin (Trelstar)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Anti-Androgens
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Enzalutamide (Xtandi)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Nilutamide (Nilandron)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Immunotherapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Sipuleucel-T (Provenge)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Targeted Therapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Radium 223 Dichloride (Xofigo)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Chemotherapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Cabazitaxel (Jevtana)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Docetaxel (Taxotere)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Prostate Cancer Therapeutics Market, By Distribution Channel, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Hospital Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Retail Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Online Pharmacies
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Prostate Cancer Therapeutics Market, By Region, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, By Region, 2017 - 2025
o North America
? Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? China
? Japan
? India
? ASEAN
? Australia
? South Korea
? Rest of Asia Pacific
o Latin America
? Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? Northern Africa
? Central Africa
? South Africa
o Middle East
? Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? GCC Countries
? Israel
? Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Johnson & Johnson
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Astellas Pharma, Inc
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Sanofi
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Bayer AG
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? AstraZeneca Plc
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Pfizer, Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Dendreon Corporation (Sanpower Group Co. Ltd.)
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Ipsen Group
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Tolmar Inc
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? Endo International plc
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
? AbbVie, Inc.
? Company Overview
? Technology Portfolio
? Financial Performance
? Recent Developments/Updates
? Strategies
8. Section
o Analyst Views
o Research Methodology
o About Us and Sales Contact
*Browse 29 market data tables and 33 figures on "Prostate Cancer Therapeutics Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.